Elsevier

Journal of Hepatology

Volume 41, Issue 6, December 2004, Pages 1050-1059
Journal of Hepatology

Special article
Strategies for liver support: from stem cells to xenotransplantation

Summary of an EASL MONOTHEMATIC CONFERENCE held in Venice, September 25 and 26, 2003. Additional invited speakers were: N. Fausto (USA), D. Tosh (UK), E.B. Petersen (USA), M. Alison (UK), D.A. Shafritz (USA), M. Strazzabosco (Italy), D. Adams (UK), M. Pinzani (Italy), S. Forbes (UK), H. Gilgenkrantz (France), E. Cozzi (Italy), U. Baccarani (Italy), M. Muraca (Italy), I. Fox (USA), J. Gerlach (USA), R.A. Chamuleau (The Netherlands), F.S. Larsen (Denmark), and A. Bader (Germany).
https://doi.org/10.1016/j.jhep.2004.10.003Get rights and content

Introduction

The continuing shortage of donor organs has been a major roadblock in orthotopic liver transplantation (OLT). This has led to the consideration of several potentially viable alternatives, including bioartificial and nonbiological liver assist devices, transplantation of mature hepatocytes or of stem/progenitor cells, and potential of transplanting xenogeneic organs and cells. Numerous investigators throughout the world are engaged in these investigations and the pace of discovery has begun to accelerate in recent years. To obtain an overview of progress in these areas, EASL sponsored a Monothematic Conference, which was held in Venice on 25th-26th September 2003.

This conference was characterized by the enthusiastic participation of many leading investigators from various parts of the world. The present paper is a summary of the Monothematic Conference, including the related discussion and highlights some of the controversies in the areas of stem cells and transplantation. Since any such summary obviously cannot do full justice to the presentations and discussions at the conference, we apologize in advance for inadvertent omissions or lack of suitable emphasis on specific points.

The conference was divided into several major sessions dealing with the biology of stem cells and nonparenchymal liver cells; basic aspects of hepatocyte transplantation; genetic and other manipulations of cells from the perspective of clinical applications; hepatocyte transplantation in people; and strategies for engineering bioartificial liver and nonbiological liver support devices. Moreover, several investigators presented ongoing research in relevant areas of stem cell biology.

Section snippets

General principles concerning modification of cells

Insights into mechanisms of cell engraftment and proliferation are critical for cell therapy. In animals, transplanted cells can repopulate the liver following injury or inhibition of proliferation in native cells with various manipulations [1], [2], [3], [4], [5], [6]. Dr. S. Gupta provided an overview of mechanisms concerning transplanted cell engraftment and proliferation. Also, he reviewed suitable targets for liver cell therapy, which extend from metabolic disorders, e.g. Crigler-Najjar

Potential of stem cells and mechanisms in liver regeneration

Identification of suitable additional sources of cells that could be transplanted in lieu of hepatocytes should be effective for cell therapy applications. In this pursuit, attention has been focused on embryonic stem (ES) cells and nonhepatic stem cells.

Immunological mechanisms involving hepatic dendritic and endothelial cells

The liver is an immunologically active organ and Dr. D. Adams reviewed this area. The liver is constantly exposed to gut antigens via the portal vein, to local pathogens via the biliary tree, and to systemic pathogens via the hepatic artery. Analysis of T cells in the liver following exposure to cytomegalovirus identified presence of specific CD8+T cell fractions, including long-lived viral memory cells that are sequestered in the liver [43], [44]. The nature of the cytokine and costimulatory

Role of hepatic stellate cells in tissue remodeling

Insights into the regulation of stromal development and maintenance will facilitate tissue engineering. Also, interactions among parenchymal cells and other cells are often modulated by stromal elements. Dr. M. Pinzani reviewed the biology of the hepatic stroma and the role of hepatic stellate cells in this process. Inflammatory, infectious and other processes can all damage the stroma and in response to these processes, cells capable of producing extracellular matrix components (ECM) are often

Challenges in transplanting cells in patients, liver support systems and xenografts

The ability to cryopreserve cells is critical for clinical programs so that cell preparations can be characterized beforehand and cells can be transplanted under better controlled settings. Transplantation of freshly isolated cells is beset with difficulties concerning the unpredictability of donor organ availability and eventual viability of cells. The general goal of cell cryopreservation is to obtain the highest viability of cells after thawing. In practice, the viability of cryopreserved

Conclusions

This EASL Monothematic Conference helped to focus attention on recent progress in mechanisms regulating liver regeneration, the role of hepatic stem cells in liver regeneration, and the potential various types of extrahepatic stem cells in liver regeneration. The impact of cell transplantation and xenotransplantation in human disease was reviewed. Finally, progress in the areas of liver bioassist devices and other devices was discussed. The general agreement was that further work is needed to

First page preview

First page preview
Click to open first page preview

References (103)

  • N.D. Theise et al.

    Bone marrow to liver: the blood of Prometheus

    Semin Cell Dev Biol

    (2002)
  • O. Yasui et al.

    Isolation of oval cells from Long-Evans Cinnamon rats and their transformation into hepatocytes in vivo in the rat liver

    Hepatology

    (1997)
  • T. Fujikawa et al.

    Purification of adult hepatic progenitor cells using green fluorescent protein (GFP)-transgenic mice and fluorescence-activated cell sorting

    J Hepatol

    (2003)
  • A.J. Grant et al.

    Hepatic expression of secondary lymphoid chemokine (CCL21) promotes the development of portal associated lymphoid tissue in chronic inflammatory liver disease

    Am J Pathol

    (2002)
  • A. Bonacchi et al.

    The chemokine CCL 21 modulates lymphocyte recruitment and fibrosis in chronic hepatitis

    C. Gastroenterology

    (2003)
  • P.J. O'Connell et al.

    CD8alpha+(lymphoid related) and CD8alpha− (myeloid) dendritic cells differentially regulate vascularized organ allograft survival

    Transplant Proc

    (2001)
  • I.J. Fox et al.

    Hepatocyte transplantation

    Am J Transpl

    (2004)
  • I.J. Fox et al.

    Hepatocyte transplantation

    J Hepatol

    (2004)
  • N.L. Sussman et al.

    Extracorporeal liver support: cell-based therapy for the failing liver

    Am J Kidney Dis

    (1997)
  • M. Irgang et al.

    Porcine endogenous retroviruses: no infection in patients treated with a bioreactor based on porcine liver cells

    J Clin Virol

    (2003)
  • J.F. Patzer et al.

    Bioartificial liver program investigators. Preclinical evaluation of the Excorp Medical, Inc, Bioartificial Liver Support System

    J Am Coll Surg

    (2002)
  • G.V. Mazariegos et al.

    First clinical use of a novel bioartificial liver support system (BLSS)

    Am J Transplant

    (2002)
  • A.J. Ellis et al.

    Pilot-controlled trial of the extracorporeal liver assist device in acute liver failure

    Hepatology

    (1996)
  • U. Heemann et al.

    Albumin dialysis in cirrhosis with superimposed acute liver injury. A prospective, controlled study

    Hepatology

    (2002)
  • S.R. Mitzner et al.

    Improvement of hepatorenal syndrome with extracorporeal albumin dialysis MARS: results of a prospective, randomized, controlled trial

    Liver Transpl

    (2000)
  • K. Rifai et al.

    Prometheus—a new extracorporeal system for the treatment of liver failure

    J Hepatol

    (2003)
  • H. Nagata et al.

    Treatment of cirrhosis and liver failure in rats by hepatocyte xenotransplantation

    Gastroenterology

    (2003)
  • M. Dandri et al.

    Woodchuck hepatocytes remain permissive for hepadnavirus infection and mouse liver repopulation after cryopreservation

    Hepatology

    (2001)
  • R.Y. Calne et al.

    Pig to babbon liver xenografts

    Lancet

    (1968)
  • Z.E. Holzknecht et al.

    Immune complex formation after xenotransplantation: evidence of type III as well as type II immnue reactions provide clues to pathophysiology

    Am J Pathol

    (2001)
  • J.A. Rhim et al.

    Replacement of diseased mouse liver by hepatic cell transplantation

    Science

    (1994)
  • K. Overturf et al.

    Hepatocytes corrected by gene therapy are selected in vivo in a murine model of hereditary tyrosinaemia type I

    Nat Genet

    (1996)
  • A. Mignon et al.

    Selective repopulation of normal mouse liver by Fas/CD95-resistant hepatocytes

    Nat Genet

    (1998)
  • C. Guha et al.

    Amelioration of radiation induced liver damage in partially hepatectomized rats by hepatocyte transplantation

    Cancer Res

    (1999)
  • H. Malhi et al.

    Cell transplantation after oxidative hepatic preconditioning with radiation and ischemia-reperfusion leads to extensive liver repopulation

    Proc Natl Acad Sci USA

    (2002)
  • M. Grossman et al.

    Successful ex vivo gene therapy directed to liver in a patient with familial hypercholesterolaemia

    Nature Genet

    (1994)
  • M. Grossman et al.

    A pilot study of ex vivo gene therapy for homozygous familial hypercholesterolaemia

    Nat Med

    (1995)
  • H. Wege et al.

    In vitro expansion of human hepatocytes is restricted by telomere-dependent replicative aging

    Cell Transplant

    (2003)
  • M. Zalzman et al.

    Reversal of hyperglycemia in mice by using human expandable insulin-producing cells diffentiated from fetal liver progenitor cells

    PNAS

    (2003)
  • B.E. Petersen et al.

    Bone marrow as a potential source of hepatic oval cells

    Science

    (1999)
  • N.D. Theise et al.

    Derivation of hepatocytes from bone marrow cells in mice after radiation-induced myeloablation

    Hepatology

    (2000)
  • E. Lagasse et al.

    Purified hematopoietic stem cells can differentiate into hepatocytes in vivo

    Nat Med

    (2000)
  • M.R. Alison et al.

    Hepatocytes from nonhuman adult stem cells

    Nature

    (2000)
  • A.J. Wagers et al.

    Little evidence for developmental plasticity of adult hematopoietic stem cell

    Science

    (2002)
  • X. Wang et al.

    Kinetics of liver repopulation after bone marrow transplantation

    Am J Pathol

    (2002)
  • X. Wang et al.

    Cell fusion is the principal source of bone-marrow-derived hepatocytes

    Nature

    (2003)
  • G. Vassilopoulos et al.

    Transplanted bone marrow regenerates liver by cell fusion

    Nature

    (2003)
  • F.V. Chisari et al.

    Hepatitis B virus immunopathogenesis

    Ann Rev Immunol

    (1995)
  • F.D. Camargo et al.

    Hematopoietic myelomonocytic cells are the major source of hepatocyte fusion partners

    J Clin Invest

    (2004)
  • H. Willenbring et al.

    Myelomonocytic cells are sufficient for therapeutic cell fusion in liver

    Nat Med

    (2004)
  • Cited by (5)

    • Experimental hepatology applied to stem cells

      2008, Digestive and Liver Disease
      Citation Excerpt :

      More and more patients are referred for transplant surgery, and the waiting lists are growing longer because not enough organs and tissues are donated for transplantation. This has led to several potentially viable alternatives being considered, including bio-artificial support devices, the transplantation of mature cells or stem/progenitor cells and the potential transplantation of xenogenic organs and cells [1]. Numerous investigators around the world are engaged in these investigations and the pace of discovery has begun to accelerate in recent years.

    • Cell-free artificial liver support

      2006, Therapeutic Apheresis and Dialysis
    View full text